Table 7 Significantly enriched pathways in intersection of (1) and (4) or unique to (2) from Fig. 4
Pathway | (1) NES | (2) NES | (4) NES |
|---|---|---|---|
KEGG SYSTEMIC LUPUS ERYTHEMATOSUS | 1.76 | 2.56 | 2.29 |
PID SMAD2 3NUCLEAR PATHWAY | 1.91 | 2.24 | 1.85 |
PID P53 DOWNSTREAM PATHWAY | 1.86 | 2.26 | 1.84 |
PID AP1 PATHWAY | 1.8 | 2.1 | 2.03 |
REACTOME HEMOSTASIS | 1.46 | 1.87 | 1.46 |
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION | 1.52 | 2.56 | 1.76 |
REACTOME INNATE IMMUNE SYSTEM | 1.52 | 2.16 | 1.4 |
BIOCARTA CK1 PATHWAY | NS | -1.88 | NS |
REACTOME INSULIN SYNTHESIS AND PROCESSING | NS | -1.85 | NS |
PID REG GR PATHWAY | NS | 1.56 | NS |
KEGG GLYCOSAMINOGLYCAN BIOSYNTHESIS HEPARAN SULFATE | NS | -1.75 | NS |
REACTOME NEUROTRANSMITTER RELEASE CYCLE | NS | -1.7 | NS |
KEGG ARACHIDONIC ACID METABOLISM | NS | 1.58 | NS |
PID HNF3A PATHWAY | NS | 1.61 | NS |
REACTOME POTASSIUM CHANNELS | -1.78 | NS | -1.74 |
BIOCARTA NFAT PATHWAY | 1.95 | NS | 1.87 |